Sara Duterte calls corruption a 'progressive disease' in government
Politics

Sara Duterte calls corruption a 'progressive disease' in government

Vice President Sara Duterte described corruption as a 'progressive disease' embedded in the government, hindering Filipinos' future. Her remarks at a business conference highlight concerns over economic growth and governance.

Read up to 3 eligible full articles per Japan day (JST) for free

Create a free account to open up to 3 eligible full articles per Japan calendar day (JST). Headlines and summaries remain available across ASEAN 7.

  • VP's Ex-Staffers Issue: A Smokescreen for Impeachment Trial?

    A spokesperson for the House prosecution in the impeachment trial suggested that allegations concerning former household staff of Vice President Sara Duterte might be a "smokescreen" to divert attention from the core impeachment issue. Duterte's camp claims the staff were pressured to sign affidavits with false allegations.

  • Bayan Vows Continued Protests Post-Trump, Targets Marcos Jr. on Public Funds

    Philippine alliance Bagong Alyansang Makabayan (Bayan) announced it will continue protests after US President Donald Trump's departure, vowing to hold President Ferdinand Marcos Jr. accountable for alleged public fund misuse. The group remains critical of the Marcos administration's policies.

  • US Approves Over $5 Billion in Arms Sales to Philippines, Cites Deepening Defense Ties

    US President Donald Trump announced over $5 billion in approved arms sales and increased foreign military financing for the Philippines, signaling expanded defense cooperation amid South China Sea tensions. He also highlighted efforts to bolster US defense manufacturing capacity.

  • Foreign Chambers Welcome EO on Land Use, But Urge Passage of NLUA

    Foreign chambers in the Philippines welcome the planned issuance of an executive order (EO) clarifying agency roles in land use planning. However, they emphasize the passage of the National Land Use Act (NLUA) is crucial for reducing regulatory uncertainty.